SPECT-CT vs MRI to diagnose foot and ankle arthritis
Part of Bones, joints & muscles clinical trials.
This study compares two imaging tests—SPECT-CT and MRI—to see which one best helps diagnose osteoarthritis (wear-and-tear joint arthritis) in the ankle and midfoot/hindfoot. It may help confirm the right diagnosis so treatment can be better targeted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have symptoms in your ankle or midfoot/hindfoot that make arthritis seem likely.
- Your average pain score is 4 or higher (on a 0–10 scale) over the past week.
- You can give informed consent and understand the study information.
- You do not have conditions that prevent you from having SPECT-CT, MRI, injections, or surgery if needed.
- Your problem is not just the front part of the foot, and you have not had foot/ankle surgery on the affected side.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a special type of bone scan (called triphasic bone scan and SPECT/CT) can accurately diagnose osteoarthritis in the foot or ankle. If you have chronic pain in these areas, participating may help confirm if osteoarthritis is the cause.
This study tests whether a special CT scan with gentle stress maneuvers can better find ankle ligament injury (syndesmotic instability) after a sprain. If you had a recent ankle sprain and exam suggests this specific injury, the scan may help guide the right treatment.
This study uses a special type of scan called PET/MRI to look for areas in the body that may be causing ongoing pain after joint replacement or arthroscopy. It aims to better understand why some people have pain that lasts months after surgery.
This study uses imaging (an exam plus ultrasound and MRI) to help understand causes of pain between the toes, such as a small pad inflammation or nerve irritation (Morton’s neuroma). It may help researchers better match imaging findings to the likely cause of your symptoms.
This trial tests a new imaging scan (SPECT) that uses a special tracer (99mTc-TCR-FAPI) to see inflammation in the joints of people with rheumatoid arthritis. It aims to help doctors better understand and track disease activity.
This trial tests whether adding a special MRI technique (T2 mapping) to a routine knee scan helps doctors see early signs of osteoarthritis more clearly. If you have knee OA and meet the safety requirements for MRI, you might be eligible.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.